News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Shorts

Mauro Cives, MD, discussed a surprising finding in his research, which won an investigator award from the Neuroendocrine Tumor Research Foundation.

Some TILs May Exploit Antitumor Activity in Pancreatic NETs

5 months ago

by

Mauro Cives, MD

$Shambavi Richard, MD, spoke with CancerNetwork® about findings from the phase 1b portion of the DURGA-1 trial (NCT05850234) assessing AZD0120, a novel BCMA/CD19 dual-targeting cellular therapy, among those with relapsed/refractory multiple myeloma.$

AZD0120 Shows “Excellent” Response Rates in R/R Multiple Myeloma

5 months ago

by

Shambavi Richard, MD

Dominique Rash, MD, highlighted what patient factors and characteristics guide how radiation oncologists coordinate utilizing radiation with systemic therapy for patients with inoperable endometrial cancer.

Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer

5 months ago

by

Dominique Rash, MD

Why Survivorship is the Next Phase of Cancer Research

Why Survivorship is the Next Phase of Cancer Research

5 months ago

by

Fumiko Chino, MD

$In a conversation with CancerNetwork® at the 2026 American College of Radiation Oncology (ACRO) Summit, Pranshu Mohindra, MD, discussed the evolution of hypofractionated radiotherapy in the lung cancer field, which may help expedite the treatment process for patients$

How Has Hypofractionation Made Lung Cancer Radiotherapy More Convenient?

5 months ago

by

Pranshu Mohindra, MD

Monzr M. Al Malki, MD, described TRX103, an off-the-shelf allogenic T-cell therapy, contextualized by a presentation he gave at the 2026 Tandem Meetings.

TRX103: The Future of Allogeneic T-Cell Therapy?

5 months ago

by

Monzr Al Malki, MD

When to Use Checkpoint Inhibitors in Sarcoma Therapy

When to Use Checkpoint Inhibitors in Sarcoma Therapy

5 months ago

by

Seth M. Pollack, MD

Vanessa Almendro Navarro, PhD, MBA, encourages her colleagues to envision an ideal state of City of Hope as an organization as opposed to succumbing to the fear of change.

Overcoming Fear to Change in the Commercialization Aspect of Oncology

5 months ago

by

Vanessa Almendro Navarro, PhD, MBA

Irtiza N. Sheikh, DO, touched upon key questions that emerged following the publication of research evaluating liso-cel between patients younger than 50 and those 50 years and older in both the real-world and clinical trial settings.

Highlighting Key Questions in Liso-Cel Treatment Across Lymphoma Settings

5 months ago

by

Irtiza N. Sheikh, DO

Vanessa Almendro Navarro, PhD, MBA, highlighted the importance of collaboration between oncology departments to facilitate drug development for use in oncology care.

Collaboration Across Departments is Key in Oncology Development

5 months ago

by

Vanessa Almendro Navarro, PhD, MBA

Looking back at the long-term effects of the COVID-19 pandemic on oncology care, Daniel C. McFarland, DO, spoke with CancerNetwork® about how this health crisis impacted his interactions with patients from a psycho-oncology perspective.

COVID-19 Was ‘Added Layer of Trauma’ in Psycho-Oncology Care

5 months ago

by

Daniel C. McFarland, DO

Personalizing Diet Based on Patient Risk and Metabolism

Personalizing Diet Based on Patient Risk and Metabolism

5 months ago

by

Ifeoma Dikeocha, PhD

Irtiza N. Sheikh, DO, discussed key efficacy findings from a comparative analysis of liso-cel among patients younger than 50 with large B-cell lymphoma (LBCL) in the real-world and clinical trial settings.

Data Show Similar Liso-Cel Efficacy in Young LBCL Groups Across Settings

5 months ago

by

Irtiza N. Sheikh, DO

The Missing Link in Cancer Research: Diversity

The Missing Link in Cancer Research: Diversity

5 months ago

by

Kathie-Ann Joseph, MD, MPH, FACS

A study published in Lancet Oncology demonstrated that radiation is a feasible method to treat celiac plexus-associated pain in patients with gastrointestinal cancers.

Using Radiation to Treat Celiac Plexus-Associated Pain in GI Cancers

5 months ago

by

Michael Buckstein, MD, PhD

Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation

Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation

5 months ago

by

Parul Barry

Beyond Mastectomy: The Power of Oncoplastic Surgery

Beyond Mastectomy: The Power of Oncoplastic Surgery

5 months ago

by

Kathie-Ann Joseph, MD, MPH, FACS

ACRO Day 2 Quick Take With CancerNetwork

ACRO Day 2 Quick Take With CancerNetwork

5 months ago

by

Ariana Pelosci(+1 more)

The Complex Decisions in Treating DCIS Breast Cancer

The Complex Decisions in Treating DCIS Breast Cancer

5 months ago

by

Jean L. Wright, MD, FASTRO

Yun Rose Li, MD, PhD, spoke about the inspiration behind her team’s assessment of cardiovascular risks with hormone therapy for prostate cancer in the phase 2 IMPACT-ADT trial.

STEMI Event Inspires Prostate Cancer Trial Assessing Cardiovascular Risk

5 months ago

by

Yun Rose Li, MD, PhD

As part of a conversation with a CancerNetwork®, Manoj Bhasin, PhD, MS, discussed the next steps for refining the development of next-generation therapies for patients with newly diagnosed multiple myeloma (NDMM) following novel translational findings that he and colleagues published in Nature Cancer.

Translating Cytogenetic Data Into Next-Generation Therapies in NDMM

5 months ago

by

Manoj Bhasin, PhD, MS

ACRO Day 1 Quick Take With CancerNetwork

ACRO Day 1 Quick Take With CancerNetwork

5 months ago

by

Ariana Pelosci(+1 more)

Yun Rose Li, MD, PhD, discussed a balancing act when considering treatment with hormone therapy for patients with late-stage prostate cancer, particularly those who are at a higher risk of cardiovascular events.

Balancing Cardiovascular and Prostate Cancer Risks in Oncology Treatment

6 months ago

by

Yun Rose Li, MD, PhD

In honor of World Cancer Day, Paolo Tarantino, MD, spoke with CancerNetwork® about the current state of the oncology field and how it may continue to evolve.

Social Media and AI Are Expanding With the Data in Oncology Research

6 months ago

by

Paolo Tarantino, MD, PhD

How Can Diet Improve Chemotherapy Results?

How Can Diet Improve Chemotherapy Results?

6 months ago

by

Ifeoma Dikeocha, PhD

Arturo Loaiza-Bonilla, MD, MSEd, FACP, touched upon studies such as the PANORAMA trial, which assessed early detection of pancreatic cancers through AI–assisted CT scans.

Employing Artificial Intelligence to Detect Early-Stage Pancreatic Cancer

6 months ago

by

Arturo Loaiza-Bonilla, MD, MSEd, FACP

What is Inflammatory Breast Cancer?

What is Inflammatory Breast Cancer?

6 months ago

by

Kathie-Ann Joseph, MD, MPH, FACS

Arturo Loaiza-Bonilla, MD, MSEd, FACP, discussed the ability of large foundational AI models to democratize pathology readouts by providing biomarkers with an H&E stain or a slide in the absence of readily available pathologist.

Democratizing Pathology in Oncology with Artificial Intelligence

6 months ago

by

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Neoadjuvant Radiation in Sarcoma: Does it Change Surgical Ease?

Neoadjuvant Radiation in Sarcoma: Does it Change Surgical Ease?

6 months ago

by

Emily J. Papai, MD

Why Early Dietary Support in Cancer is Vital

Why Early Dietary Support in Cancer is Vital

6 months ago

by

Ifeoma Dikeocha, PhD

Trending on CancerNetwork

Study Redefines Functional High-Risk Multiple Myeloma in Modern-Therapy Era

ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates

Sequencing Treatment after EV-Pembro in Urothelial Carcinoma

Managing Safety and Infection Risk With Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?